Lois Krahn, MD
Psychiatry · Scottsdale, AZNPI 1568446854
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,944 of the $32,067 with a category attached, or 84.0%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 86.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $22,789, more than ten times the $85 reported in 2019. Among psychiatry clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $801.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$28K
- Harmony Biosciences LLC$3K
- Avadel CNS Pharmaceuticals, LLC$1K
- Jazz Pharmaceuticals Inc.$467
- Idorsia Pharmaceuticals US Inc$47
Across 48 payments — averaging $3444.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$140K
- Jazz Pharmaceuticals Inc.$23K
- Harmony Biosciences LLC$3K
What the payments were for
- Consulting fees$26,94484%
- Travel & lodging$3,60611%
- Food & beverage$1,5175%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $27,664 |
| Harmony Biosciences LLC | 4 | $2,654 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $1,236 |
| Jazz Pharmaceuticals Inc. | 4 | $467 |
| Idorsia Pharmaceuticals US Inc | 1 | $47 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$32,067 in reported general payments places this provider in the 95th percentile of 573 psychiatry providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 11 | $115 |
| Clonazepam | 24 | $114 |
| Zolpidem Tartrate | 16 | $106 |
| Trazodone Hcl | 17 | $78 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Scottsdale
- Henry SchulteScottsdale$77K
- Lauren BonnerScottsdale$44K
- Alvin BursteinScottsdale$18K
- Marie GronleyScottsdale$8K
- Alpa SanghviScottsdale$6K
- Adam KoelschScottsdale$5K
- Elizabeth RotellaScottsdale$4K
- Supriya NairScottsdale$4K
- Paul ValbuenaScottsdale$4K
- Jason CaplanPhoenix$999K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.